Arasid 1000mg Injection, Intas Pharmaceuticals Ltd

Patent medicine name

Manufacturer

Specification

Price

Generic medicine name & Manufacturer

Arasid 1000mg Injection, Intas Pharmaceuticals Ltd

Specification

Physical Form: Injection, Quantity: 1 vial/box, Storage: Room Temperature(10-30°C)

Price

$10-20

Composition

Cytarabine (1000mg)

Use

It is used in the treatment of ovarian cancer, head and neck cancer, cervical cancer, Testicular cancer., breast cancer, non-Hodgkin lymphoma (NHL), blood cancer, lung cancer, bone cancer and urinary bladder cancer.

Medicince introduction including background, function, caution, etc.

Indication
For The Treatment Of Acute Non-lymphocytic Leukemia, Acute Lymphocytic Leukemia And Blast Phase Of Chronic Myelocytic Leukemia.

Side Effects
Hepatic And Renal Dysfunction, Neurotoxicity, Rashes, Oral And Anal Ulceration

Mechanism Of Action
Cytarabine Acts Through Direct DNA Damage And Incorporation Into DNA. It Exhibits Cell Phase Specificity, Primarily Killing Cells Undergoing DNA Synthesis (S-phase) And Under Certain Conditions Blocking The Progression Of Cells From The G1 Phase To The S-phase.

Use in Other language

Picture